| Anne Wojdacz, CRNA | |
|
4483 Oakhill Blvd, Lorain, OH 44053-1959 | |
| (440) 282-3358 | |
| Not Available |
| Full Name | Anne Wojdacz |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 4483 Oakhill Blvd, Lorain, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154459519 | NPI | - | NPPES |
| 305565500 | Medicaid | FL | |
| G3188 | Other | FL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN135183 (Ohio) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP 9172911 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Anne Wojdacz, CRNA 4483 Oakhill Blvd, Lorain, OH 44053-1959 Ph: (440) 282-3358 | Anne Wojdacz, CRNA 4483 Oakhill Blvd, Lorain, OH 44053-1959 Ph: (440) 282-3358 |
News Archive
Spectrum Pharmaceuticals today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.
Quebec Parkinson researchers receive a record $573,384 in funding from Parkinson Society Canada to increase their efforts to identify the causes of this degenerative brain disease for which there is currently no cure. At a Research Innovation event in Montreal this evening, hosted by Parkinson Society Quebec in partnership with McGill University and the CHUM, 11 Parkinson scientists will be lauded for their efforts in getting closer to a cure.
The Muscular Dystrophy Association today announced it has awarded $1.4 million in new research funding to the biopharmaceutical firm Repligen of Waltham, Mass., to complete the preclinical work needed to begin human clinical trials of a promising therapeutic compound for spinal muscular atrophy (SMA).
The majority of antidepressants prescribed to treat children and teenagers with major depression are ineffective and may even be unsafe, warn researchers.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, today announced that an IRB approved, randomized, vehicle-controlled, double-blinded study conducted at Centers for Allergy and Asthma in Denver, Colorado indicates that Ampion provides safe and effective anti-inflammatory relief when administered intranasally to patients with nasal inflammation.
› Verified 5 days ago
William J Hartman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-323-8515 | |
Safeta S Hagen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-323-8515 Fax: 440-323-7900 | |
Steven Lucius, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-323-8515 Fax: 440-323-7900 | |
Allison E Vargo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-960-4000 | |
Ms. Virginia A Stevenson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-323-8515 Fax: 440-323-7900 | |
Carla J Campbell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-323-8515 Fax: 440-323-7900 |